Effects of quinapril on coronary blood flow in coronary artery disease patients with endothelial dysfunction

American Journal of Cardiology

Volumn 80, Issue 12, 1997, Pages 1594-1597

  Schlaifer, Jay D ^a   Wargovich, Thomas J ^b   O'Neill, Blair ^b   Mancini, G B John ^c   Haber, Harry E ^d   Pitt, Bertram ^e   Pepine, Carl J ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b DALHOUSIE UNIVERSITY   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d PFIZER INC   (United States)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

QUINAPRIL;

ADULT; AGED; ARTICLE; BINDING AFFINITY; CLINICAL ARTICLE; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; DRUG POTENCY; ENDOTHELIUM CELL; FEMALE; HEART PERFUSION; HUMAN; MALE; PRIORITY JOURNAL; RESISTANCE BLOOD VESSEL;

ACETYLCHOLINE; ADENOSINE; ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD FLOW VELOCITY; CORONARY CIRCULATION; CORONARY DISEASE; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; ISOQUINOLINES; MALE; MICROCIRCULATION; MIDDLE AGED; NITROGLYCERIN; PILOT PROJECTS; TETRAHYDROISOQUINOLINES; VASODILATOR AGENTS;

EID: 0031436138     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)00750-9     Document Type: Article

References (17)

1. Yamamoto H, Bossalier C, Cartwright J, Henry PD. Videomicroscopic demonstration of defective cholinergic arteriolar vasodilation in atherosclerotic rabbit. J Clin Invest. 81:1988;1752-1758.
2. Selke FW, Armstrong ML, Harrison DG. Endothelium-dependent vascular relaxation is abnormal in the coronary microcirculation of atherosclerotic primates. Circulation. 81:1990;1586-1593.
3. Zeiher AM, Drexler H, Wollschläger H, Just H. Endothelial dysfunction of the coronary microvasculature is associated with impaired coronary blood flow regulation in patients with early atherosclerosis. Circulation. 84:1991;1984-1992.
4. Egashira K, Inou T, Hirooka Y, Ysamada A, Marouka Y, Kai H, Sigimachi M, Suzuki S, Takeshita A. Impaired coronary blood flow response to acetylcholine in patients with coronary risk factors and proximal atherosclerotic lesions. J Clin Invest. 91:1993;29-37.
5. Zeiher AM, Drexler H, Saurbier B, Just H. Endothelium-mediated coronary blood flow modulation in humans effects of age, atherosclerosis, hypercholesterolemia, and hypertension . J Clin Invest. 92:1993;652-662.
6. Mancini GBJ, Henry GC, Macaya C, O'Neill BJ, Pucillo AL, Carere RG, Wargovich TJ, Mudra H, Lüscher TF, Klibaner MI, Haber HE, Uprichard ACG, Pepine CJ, Pitt B. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease the TREND (Trial on Reversing ENdothelial Dysfunction) study . Circulation. 94:1996;258-265.
7. Becker R, Wiemer G, Linz W. Preservation of endothelial function by ramipril in rabbits on a long-term atherogenic diet. J Cardiovasc Pharm. 18:(suppl 2):1991;S110-S115.
8. Finta KM, Fischer MJ, Lee L, Gordon D, Pitt B, Webb RC. Ramipril prevents impaired endothelium-dependent relaxation in arteries from rabbits fed an atherogenic diet. Atherosclerosis. 100:1993;149-156.
9. Mancini GBJ, Simon SB, McGillern Lefree MT, Friedman HZ, Vogel RA. Automated quantitative coronary arteriography morphologic and physiologic validation in vivo of rapid digital angiographic method . Circulation. 75:1987;452-460.
10. Doucette JW, Corl PD, Payne HM, Flynn AE, Goto M, Nassi M, Segal J. Validation of a Doppler guidewire for intravascular measurement of coronary artery flow velocity. Circulation. 85:1992;1899-1911.
11. Ofili E, Karim M, Kern M, Deligonul U, Aguirre F, Serota H, Tatineni S. Simultaneous comparison of intracoronary spectral and zero cross flow velocity measurements by Doppler angioplasty guidewire and catheter techniques. J Am Coll Cardiol. 17:1991;124A.
12. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med. 327:1992;685-691.
13. Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ, Cuddy TE, Davis BR, Geltman EM, Goldman S, Flaker GC, Klein M, Lamas GA, Packer M, Rouleau J, Rouleau JL, Rutherford J, Wertheimer JH, Hawkins CM. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 327:1992;669-677.
14. Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet. 343:1995;1115-1122.
15. ISIS-4 a randomized factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction . Lancet. 345:1995;669-685.
16. Lonn EM, Yusuf S, Jha P, Montague TJ, Teo KK, Benedict CR, Pitt B. Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection. Circulation. 90:1994;2056-2069.
17. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res. 74:1994;1141-1148.